Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
Year: 2017
Type: article
Abstract: Cyclin-dependent kinase 9 (CDK9), a member of the cyclin-dependent protein kinase (CDK) family, is involved in transcriptional elongation of several target genes. CDK9 is ubiquitously expressed and has been shown to contribute to a variety of malignancies such as pancreatic, prostate and breast cancers. Here we report the development of a heterobifunctional small molecule proteolysis targeting chimera (PROTAC) capable of cereblon (CRBN) mediated proteasomal degradation of CDK9. In HCT116 cells, it selectively degrades CDK9 while sparing other CDK family members. This is the first example of a PROTAC that selectively degrades CDK9.
Source: Chemical Communications
DOI: 10.1039/c7cc03879h
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer, Regulation of cyclin D1 expression in the intestine, pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics, Cell Survival Determinants of Metastasis in IGF1R-Dependent CRC, Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers, Buffett Cancer Center Support Grant, Cancer Biology Training Program
OpenAlex ID: W2625751604
